Heinrich Zinsli

Human Genome Sciences, Inc. is a biopharmaceutical company that exists to place new therapies into the hands of those battling serious disease. Its lead products include BENLYSTA for systemic lupus erythematosus and raxibacumab for inhalation anthrax. The firm's other products include, mapatumumab, darapladib, albiglutide, ZALBIN, HGS1036 and HGS1029. The company was founded by Alan G. Walton and William A. Haseltine in 1992 and is headquartered in Gaithersburg, MD.

Part of Roche Holding AG, Corange Ltd. is a Bermudian company that manufactures orthopedic and diagnostics equipment. The company is based in Hamilton, Bermuda. Corange was acquired by Roche Holding AG on May 01, 1997 for $10,930.22 million.

Sandoz, Inc. develops, manufactures and distributes generic pharmaceutical products. The firm focuses on therapeutic drug categories such as anti-infective, central nervous system disorder treatments, cardiovascular medicines, gastrointestinal agent, oncology therapies, and respiratory therapies. The company was founded in 1946 and is headquartered in Princeton, NJ.

Compagnie Lombard Odier SCmA provides asset management solutions. The private company is based in Geneva, CH. and has a global presence of subsidiaries in several regions.

Schweizerische Rückversicherungs-Gesellschaft AG provides reinsurance, insurance, and risk management solutions. The firm focuses on the property and casualty, life and health, and asset management sectors. The company was founded on May 1, 1883 and is headquartered in Zurich, Switzerland.

Founded in 1983, Fairfield Greenwich Group's (FGG) is a hedge fund manager located in New York City. They have additional offices in New York, London and Bermuda, and representative offices elsewhere in the US, Europe, Latin America and Asia and a joint venture in Singapore.

Maus Freres SA owns and operates department stores. It controls various distribution and retail companies in Switzerland and internationally. The company was founded by Ernest Maus, Henri Maus and Leon Nordmann in November 1902 and is headquartered in Geneva, Switzerland.

Part of Novartis AG, Sandoz AG is a Swiss company that develops generic medicines and biosimilars. The company is based in Basel, Switzerland.

Part of Zimmer Biomet Holdings, Inc., ORTHOsoft ULC is a Canadian medical software development company. The company is based in Montréal, Canada. Louis-Philippe Amiot has been the CEO of the company since 1995. ORTHOsoft ULC was acquired by Zimmer Biomet Holdings, Inc. on October 16, 2007 for $46.36 million.

Credit Suisse Securities (Europe) Ltd. (Credit Suisse Europe) is the Great Britain-based brokerage subsidiary of Credit Suisse Investment Holdings (UK), itself a subsidiary of Credit Suisse Group AG (SWX: CSGN) in Switzerland. The firm was founded in 1966 and formerly known as Credit Suisse First Boston (Europe) Ltd. Headquartered in London, Credit Suisse Europe arranges financing in international capital markets, provides financial advisory services and acts as a dealer in securities, derivatives and foreign exchange on a principal and agency basis for corporate and institutional investors.

NOXXON Pharma AG operates a clinical stage biotechnology company. Its core focus is on cancer treatment. The firm offers effectiveness of cancer treatments including immuno-oncology approaches such as immune checkpoint inhibition and current standards of care such as chemotherapy and radiotherapy. The company was founded in 1997 by Sven Klussmann, Jens-Peter Fürste and Thomas Klein and is headquartered in Berlin, Germany.

Ambrilia Biopharma, Inc. discovers and develops novel treatments for viral diseases and cancer. Its product portfolio is comprised of oncology and antiviral assets, including two new formulations of existing peptides for cancer treatment, a targeted delivery technology for cancer, an HIV protease inhibitor program as well as HIV integrase and entry inhibitors, Hepatitis C virus inhibitors and anti-Influenza A compounds. The company was founded on November 27, 1986 and is headquartered in Montréal, Canada.

Part of Novartis AG, Sandoz Ltd. is a British company that develops, produces and markets medicines. The company is based in Camberley, UK and was founded in 1981.

Part of UBS Group AG, Credit Suisse Private Banking (London Branch) provides private banking services.

Part of Sator SpA, One Swiss Bank SA (Switzerland) is a company that provides investment advice. The company is based in Geneva, Switzerland. The company was founded in 2004 by Robert Pennone, Bénédict G. F. Hentsch. Grégoire Pennone has been the CEO of the company since 2015. One Swiss Bank SA (Switzerland was acquired by Banque Profil De Gestion SA on June 01, 2021 for $43.37 million.

Part of Nestlé SA, Frisco-Findus AG is a Swiss company that manufactures ice cream and other frozen food products. The company is based in Rorschach, Switzerland.

Part of Leggett & Platt, Inc., Spühl AG is a world-leading manufacturer of high-tech wire processing machines. The company is based in Wittenbach, Switzerland. Spühl AG's expertise lies in the production of wire processing machines, and they are known for their three-dimensional engineering capabilities.

Part of DevMar Equities, Inc., Avante Colombia SARL explores and produces petroleum. The company is based in Bogota, CO. Avante Colombia was acquired by DevMar Equities, Inc. from Avante Petroleum SA on March 04, 2010 for $25.22 million. Dirk J. H. Groen has been the CEO of the Colombian company since 2006.

Part of Clariant AG, Clariant SA is a Brazilian company that manufactures specialty chemicals. The company is based in São Paulo, Brazil. The company was founded in 1966. The CEO is Alberto Garcia Mendes.

Edmond de Rothschild Holding SA provides private banking and asset management services. The company was founded on March 31, 1954 and is headquartered in Pregny-Chambésy, Switzerland.

Part of Bâloise Holding AG, Bâloise Assurance SA is a Swiss company that provides housing, vehicle, and people insurance, as well as wealth management and retirement planning services. The company is based in Bâle, Switzerland.

AB2 Bio SA develops and manufactures drugs. The firm's products include Interleukin-18 Binding Protein and Proprietary Assay. The company was founded in 2010 and is headquartered in Lausanne, Switzerland.